Clinical Evaluation Of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors: A Randomized Controlled Trial
Notes for this study:
||Chester step test, mLO₂/kg/minᶜ. Mean + SD. Placebo: before 36.9 (5.9), after 40.1 (17.0). Iron: before 37.0 (7.2), after 40.5 (14.5).
|Number of Subjects
||18-29, 30-44, 45-64
In a randomized, double-blind, placebo-controlled trial, 154 female blood donors with iron deficiency but not anemia took 80 mg ferrous sulfate or placebo for 4 weeks.
Funding issues for this study:
After 4 weeks, hemoglobin and ferritin were increased more in the iron group, but there was no notable difference in the improvement of fatigue. There was also no change in fitness as measured by the Chester step test.
"BF gave lectures to both Pierre Fabre Médicament and Vifor Pharma, companies that might have an interest in the submitted work. The other authors have no competing interest."